Skip to content

Clinical trials

Phase 3 Inflammatory Bowel Diseases trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Country / region: Hungary Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20102
20116
20121
20151
20161
20182
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
Eli Lilly and Company2
GlaxoSmithKline2
InDex Pharmaceuticals2
Janssen Biotech, Inc.1
Merck Sharp & Dohme LLC1
Ocera Therapeutics1
Pfizer1
Pharmacosmos A/S1
Shield Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases17
Colitis, Ulcerative8
Crohn Disease8
Colitis3
Anemia2
Gastrointestinal Diseases2
Anemia, Iron-Deficiency1
Deficiency Diseases1
Fistula1
Intestinal Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.